EFX vs BAH vs FCN
161 measures in 16 categories, one definition each, computed from filings and market data.
BAH52.0
Booz Allen Hamilton Holding Corporation
Industrials · Consulting Services
$74.26 −0.30%$8.9B mkt cap
Score DNA
FCN61.3
FTI Consulting, Inc.
Industrials · Consulting Services
$148.53 +1.55%$4.1B mkt cap
Score DNA
Price, rebased to 100 three years ago
EFX BAH FCN · weekly adjusted closesSmart money 8Valuation 16Profitability (TTM) 12Returns on capital 11Growth 17Margin history & stability 7Liquidity (latest quarter) 7Leverage & solvency (latest quarter) 13Efficiency 11Cash flow & earnings quality 7Dividends & buybacks 9Scores & forensic checks 15Per share 7Size (TTM) 8Price performance 9Technicals 4
● marks the highest or lowest value where that direction is plainly stronger (margins, returns, coverage, leverage); multiples and yields are left unmarked. Bars show each stock's percentile within its own industry. n/a: the measure does not apply to lenders and insurers.
Smart money
8 measures| Measure | EFX | BAH | FCN |
|---|---|---|---|
| Insider open-market buys, 180d | 0 | 0 | 4 |
| Insider $ bought, 180d | — | — | $2.08M |
| Congress purchases, 180d | 0 | 0 | 1 |
| Last Congress purchase | — | — | 2026-08-12 |
| 13F net change in holders | −36 | +6 | — |
| ETFs adding shares, 30d | 959 | 417 | 212 |
| ETFs trimming, 30d | 714 | 282 | 249 |
| Net ETF funds, 30d | +245 | +135 | −37 |
Valuation
16 measures| Measure | EFX | BAH | FCN |
|---|---|---|---|
| P/E (TTM) | 27.4x
100th
|
11.5x
17th
|
16.2x
33rd
|
| PEG (P/E ÷ 3-yr EPS CAGR) | 2.49
80th
|
0.27
0th
|
2.52
100th
|
| Price / sales | 2.9x
83rd
|
0.8x
0th
|
1.0x
33rd
|
| Price / book | 4.3x
50th
|
7.4x
100th
|
3.1x
33rd
|
| Price / tangible book | — | — | 58.0x |
| Price / free cash flow | 17.1x
80th
|
8.0x
20th
|
9.9x
60th
|
| Price / operating cash flow | 11.7x
80th
|
7.4x
40th
|
10.2x
60th
|
| Enterprise value | $24.2B
100th
|
$12.6B
83rd
|
$5.2B
67th
|
| EV / sales | 3.8x
100th
|
1.1x
0th
|
1.3x
33rd
|
| EV / EBITDA | 12.8x
83rd
|
10.0x
17th
|
11.9x
50th
|
| EV / EBIT | 20.9x
100th
|
11.5x
17th
|
13.5x
33rd
|
| EV / free cash flow | 21.9x
80th
|
11.2x
40th
|
12.5x
60th
|
| Earnings yield | 3.6%
0th
|
8.7%
83rd
|
6.2%
67th
|
| FCF yield | 5.8%
33rd
|
12.5%
83rd
|
10.1%
50th
|
| Operating cash flow yield | 8.5%
33rd
|
13.5%
67th
|
9.8%
50th
|
| Graham number (per share) | $69.25
50th
|
$37.99
17th
|
$86.48
100th
|
Profitability (TTM)
12 measures| Measure | EFX | BAH | FCN |
|---|---|---|---|
| Gross margin | 55.5%
83rd
|
44.7%
67th
|
31.8%
33rd
|
| EBITDA margin | 29.5%
83rd
|
11.3%
33rd
|
11.1%
17th
|
| Operating margin | 17.9%
83rd
|
9.5%
17th
|
9.7%
33rd
|
| EBIT margin | 18.0%
83rd
|
9.8%
50th
|
9.8%
33rd
|
| Net margin | 10.7%
83rd
|
7.0%
67th
|
6.4%
50th
|
| NOPAT margin | 13.2%
83rd
|
8.2%
50th
|
7.0%
33rd
|
| FCF margin | 17.1%
83rd
|
10.1%
33rd
|
10.6%
50th
|
| Operating cash flow margin | 25.0%
83rd
|
10.8%
50th
|
10.3%
33rd
|
| R&D / revenue | 0.0%
0th
|
0.0%
0th
|
0.0%
0th
|
| SG&A / revenue | 26.2%
83rd
|
11.3%
0th
|
22.1%
50th
|
| Stock comp / revenue | 1.4%
83rd
|
0.5%
33rd
|
1.1%
67th
|
| Effective tax rate | 26.0%
50th
|
13.3%
0th
|
27.8%
67th
|
Returns on capital
11 measures| Measure | EFX | BAH | FCN |
|---|---|---|---|
| ROE (on average equity) | 14.6%
17th
|
68.6%
100th
|
15.6%
33rd
|
| ROA | 5.8%
17th
|
10.5%
83rd
|
7.2%
33rd
|
| ROIC | 8.8%
17th
|
19.0%
83rd
|
11.3%
33rd
|
| ROCE | 12.4%
17th
|
19.1%
67th
|
14.0%
33rd
|
| Return on tangible assets | 9.7%
17th
|
14.7%
83rd
|
10.9%
33rd
|
| Cash ROIC (OCF / invested capital) | 16.7%
67th
|
24.9%
83rd
|
16.6%
50th
|
| Gross profitability (GP / assets) | 23.9%
0th
|
65.1%
100th
|
35.3%
83rd
|
| ROIC, 3-yr average | 6.2%
17th
|
17.5%
83rd
|
9.2%
50th
|
| ROIC, 5-yr average | 7.8%
20th
|
15.9%
100th
|
10.9%
60th
|
| ROE, 5-yr average | 14.6%
20th
|
58.8%
100th
|
14.8%
40th
|
| Incremental ROIC | -245.1%
17th
|
12.6%
67th
|
-446.3%
0th
|
Growth
17 measures| Measure | EFX | BAH | FCN |
|---|---|---|---|
| Revenue growth (TTM YoY) | 10.3%
67th
|
-7.3%
17th
|
7.1%
50th
|
| Revenue growth (QoQ) | 3.1%
33rd
|
0.6%
0th
|
1.0%
17th
|
| Revenue CAGR, 3 yr | 8.4%
50th
|
4.7%
17th
|
6.8%
33rd
|
| Revenue CAGR, 5 yr | 6.8%
20th
|
7.0%
40th
|
8.2%
60th
|
| Gross profit CAGR, 3 yr | 0.6%
33rd
|
-1.5%
17th
|
6.7%
67th
|
| Operating income CAGR, 3 yr | 10.1%
33rd
|
30.6%
83rd
|
6.4%
0th
|
| Net income growth (TTM YoY) | 8.1%
67th
|
-25.1%
0th
|
1.2%
50th
|
| Net income CAGR, 3 yr | 9.6%
33rd
|
38.2%
83rd
|
2.5%
0th
|
| EPS growth (TTM YoY) | 13.3%
67th
|
-22.8%
0th
|
6.8%
50th
|
| EPS CAGR, 3 yr | 11.0%
33rd
|
42.2%
100th
|
6.4%
17th
|
| EPS CAGR, 5 yr | -0.5%
0th
|
9.0%
60th
|
3.8%
20th
|
| FCF growth (TTM YoY) | 20.5%
50th
|
13.0%
25th
|
286.7%
100th
|
| FCF CAGR, 3 yr | 33.6%
75th
|
30.3%
50th
|
126.8%
100th
|
| Operating cash flow CAGR, 3 yr | 13.8%
50th
|
27.8%
75th
|
63.6%
100th
|
| Book value CAGR, 3 yr | 2.8%
50th
|
8.8%
83rd
|
-6.0%
17th
|
| Dividend CAGR, 3 yr | 8.6% | 3.8% | — |
| Sustainable growth rate | 9.2%
17th
|
44.0%
100th
|
15.6%
33rd
|
Margin history & stability
7 measures| Measure | EFX | BAH | FCN |
|---|---|---|---|
| Gross margin, 3-yr average | 51.9%
83rd
|
51.0%
67th
|
32.1%
33rd
|
| Operating margin, 3-yr average | 18.2%
83rd
|
10.1%
33rd
|
10.0%
17th
|
| Net margin, 3-yr average | 10.8%
83rd
|
7.1%
50th
|
7.4%
67th
|
| FCF margin, 3-yr average | 15.1%
83rd
|
7.0%
17th
|
7.3%
33rd
|
| Revenue stability (0-1) | 0.96
67th
|
0.83
33rd
|
0.94
50th
|
| Earnings stability (0-1) | 0.08
0th
|
0.38
50th
|
0.15
17th
|
| Margin stability (0-1) | 0.89
0th
|
0.92
17th
|
0.98
100th
|
Liquidity (latest quarter)
7 measures| Measure | EFX | BAH | FCN |
|---|---|---|---|
| Cash & short-term investments | $170.1M
67th
|
$540.0M
100th
|
$163.7M
50th
|
| Net cash (− = net debt) | −$5.3B
0th
|
−$3.6B
17th
|
−$1.1B
33rd
|
| Working capital | −$1.0B
0th
|
$1.1B
100th
|
$804.3M
83rd
|
| Current ratio | 0.60
0th
|
1.59
50th
|
2.03
83rd
|
| Quick ratio | 0.60
0th
|
1.59
50th
|
2.03
83rd
|
| Cash ratio (cash + ST investments / current liabilities) | 0.06
33rd
|
0.28
83rd
|
0.21
67th
|
| Defensive interval (days) | 272 days
17th
|
268 days
0th
|
596 days
67th
|
Leverage & solvency (latest quarter)
13 measures| Measure | EFX | BAH | FCN |
|---|---|---|---|
| Total debt | $5.5B
100th
|
$4.2B
83rd
|
$1.3B
67th
|
| Debt / equity | 1.25
67th
|
3.46
100th
|
0.95
33rd
|
| Net debt / equity | 1.21
67th
|
3.01
100th
|
0.83
33rd
|
| Debt / assets | 45.6%
67th
|
54.7%
100th
|
35.9%
50th
|
| Debt / capital | 55.5%
67th
|
77.6%
100th
|
48.7%
33rd
|
| Debt / EBITDA | 2.88
33rd
|
3.31
83rd
|
2.91
50th
|
| Net debt / EBITDA | 2.79
50th
|
2.88
67th
|
2.53
33rd
|
| Interest coverage (EBIT / interest) | 5.2x
17th
|
11.5x
50th
|
11.6x
67th
|
| Cash interest coverage | 7.3x
33rd
|
12.7x
83rd
|
12.1x
67th
|
| Debt payback (years of OCF) | 3.4 yrs
60th
|
3.5 yrs
80th
|
3.1 yrs
40th
|
| Liabilities / assets | 62.3%
50th
|
84.2%
100th
|
62.3%
33rd
|
| IS credit model rating | BBB | A- | A+ |
| Implied credit spread (bps) | 275
67th
|
175
33rd
|
125
17th
|
Efficiency
11 measures| Measure | EFX | BAH | FCN |
|---|---|---|---|
| Asset turnover | 0.54
17th
|
1.50
100th
|
1.12
50th
|
| Fixed asset turnover | 1.89
0th
|
31.42
83rd
|
11.08
50th
|
| Inventory turnover | — | — | — |
| Receivables turnover | 6.0
83rd
|
16.5
100th
|
3.4
0th
|
| Days sales outstanding | 61 days
17th
|
22 days
0th
|
106 days
100th
|
| Days inventory outstanding | — | — | — |
| Days payables outstanding | 15 days
17th
|
39 days
83rd
|
22 days
50th
|
| Cash conversion cycle (days) | 45 days
33rd
|
−17 days
17th
|
84 days
100th
|
| Capex / revenue | 7.9%
100th
|
0.8%
20th
|
— |
| Capex / depreciation | 0.69
100th
|
0.52
60th
|
— |
| Operating expense ratio | 36.0%
83rd
|
42.3%
100th
|
23.2%
33rd
|
Cash flow & earnings quality
7 measures| Measure | EFX | BAH | FCN |
|---|---|---|---|
| Operating cash flow / net income | 2.33
83rd
|
1.55
33rd
|
1.60
67th
|
| FCF / net income | 1.60
67th
|
1.43
33rd
|
1.64
83rd
|
| FCF / operating cash flow | 68.5%
0th
|
92.8%
75th
|
— |
| Capex / operating cash flow | 31.5%
100th
|
7.2%
25th
|
— |
| Accruals ratio | -7.7%
17th
|
-5.8%
50th
|
-4.3%
67th
|
| Sloan accruals ratio | -11.2%
0th
|
-5.5%
17th
|
-1.0%
50th
|
| Earnings quality score (0-1) | 0.75
17th
|
0.75
17th
|
1.00
83rd
|
Scores & forensic checks
15 measures| Measure | EFX | BAH | FCN |
|---|---|---|---|
| IS score | 64
83rd
|
52
33rd
|
61
67th
|
| IS profitability | 54
67th
|
58
83rd
|
39
17th
|
| IS growth | 53
83rd
|
23
17th
|
46
50th
|
| IS value | 48
0th
|
70
67th
|
55
33rd
|
| IS momentum | 81
83rd
|
51
17th
|
75
50th
|
| IS risk (safety) | 80
33rd
|
80
33rd
|
90
83rd
|
| IS quality | 70
83rd
|
56
17th
|
68
50th
|
| IS balance sheet | 38
17th
|
42
33rd
|
60
83rd
|
| IS earnings quality | 67
83rd
|
68
100th
|
66
50th
|
| IS cash flow | 67
50th
|
64
33rd
|
71
83rd
|
| Piotroski F-score (0-9) | 6
17th
|
6
17th
|
6
17th
|
| Altman Z-score | 3.1
33rd
|
3.5
67th
|
3.6
83rd
|
| Beneish M-score | −2.83
0th
|
−2.68
33rd
|
−2.67
50th
|
| Ohlson O-score | −7.31
33rd
|
−6.18
67th
|
−7.31
50th
|
| IS credit score | 56
17th
|
70
67th
|
78
83rd
|
Size (TTM)
8 measures| Measure | EFX | BAH | FCN |
|---|---|---|---|
| Market cap | $18.9B
100th
|
$8.9B
83rd
|
$4.1B
67th
|
| Revenue | $6.4B
83rd
|
$11.1B
100th
|
$3.9B
67th
|
| EBITDA | $1.9B
100th
|
$1.3B
83rd
|
$435.6M
67th
|
| Net income | $691.3M
83rd
|
$778.0M
100th
|
$252.8M
67th
|
| Free cash flow | $1.1B
83rd
|
$1.1B
100th
|
$415.6M
67th
|
| Total assets | $12.0B
100th
|
$7.6B
83rd
|
$3.5B
67th
|
| Shareholders' equity | $4.4B
100th
|
$1.2B
67th
|
$1.3B
83rd
|
| Employees | 15,000
83rd
|
30,900
100th
|
8,124
50th
|
Price performance
9 measures| Measure | EFX | BAH | FCN |
|---|---|---|---|
| 1 day | −0.1% | −0.3% | +1.6% |
| 1 week | +10.6% | +0.5% | +9.1% |
| 1 month | 0.0% | −5.8% | +5.3% |
| 3 months | −10.5% | +15.1% | −7.5% |
| 6 months | −17.9% | −9.2% | −17.3% |
| Year to date | −24.7% | −11.8% | −12.8% |
| 1 year | −29.6% | −22.4% | −2.6% |
| 3 years, cumulative | −12.3% | −39.0% | −21.2% |
| 5 years, cumulative | −35.8% | −0.8% | +5.5% |
Technicals
4 measures| Measure | EFX | BAH | FCN |
|---|---|---|---|
| RSI 14 | 59.2 | 54.4 | 60.8 |
| From 52-week high | −32.4% | −31.4% | −21.6% |
| From 52-week low | +17.6% | +24.8% | +15.0% |
| Beta | 1.34 | 0.37 | -0.04 |
InsiderStreet reports findings from filings and market data. A comparison is not a recommendation to buy or sell either stock.Every figure is computed in code · data as of 2026-10-17